Joshua Allen
Technik-/Wissenschafts-/F&E-Leiter bei CHIMERIX, INC.
Aktive Positionen von Joshua Allen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CHIMERIX, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 | - |
Karriereverlauf von Joshua Allen
Ehemalige bekannte Positionen von Joshua Allen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Oncoceutics, Inc.
 Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2014 | 01.01.2021 |
Ausbildung von Joshua Allen
| University of Pennsylvania | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Oncoceutics, Inc.
Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | Health Technology |
- Börse
- Insiders
- Joshua Allen
- Erfahrung
